BG Medicine Inc. (OTCMKTS:BGMD – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. BG Medicine shares last traded at $0.00, with a volume of 0 shares changing hands.
BG Medicine Price Performance
BG Medicine Company Profile
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Recommended Stories
- Five stocks we like better than BG Medicine
- The 3 Best Blue-Chip Stocks to Buy Now
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How to Start Investing in Real Estate
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How Technical Indicators Can Help You Find Oversold Stocks
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
